JSC Kyivmedpreparat (Kyiv) posted a net loss of UAH 213.825 million in 2022 after seeing a net income of UAH 30 million in 2021.
According to the company in the information disclosure system of the National Securities and Stock Market Commission, the shareholders will consider the results of its work at a remote meeting scheduled for April 26.
The manufacturer of antibiotics Kyivmedpreparat together with JSC Galychpharm are the main manufacturers of Arterium products (Kyiv).
